0.68
price down icon3.74%   -0.0264
after-market Dopo l'orario di chiusura: .69 0.010 +1.47%
loading
Precedente Chiudi:
$0.7064
Aprire:
$0.7059
Volume 24 ore:
107.21K
Relative Volume:
0.38
Capitalizzazione di mercato:
$7.00M
Reddito:
-
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-0.1139
EPS:
-5.97
Flusso di cassa netto:
$-28.20M
1 W Prestazione:
-3.27%
1M Prestazione:
-10.80%
6M Prestazione:
-79.52%
1 anno Prestazione:
-95.85%
Intervallo 1D:
Value
$0.67
$0.7195
Intervallo di 1 settimana:
Value
$0.67
$0.738
Portata 52W:
Value
$0.65
$26.25

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name
Nome
Citius Pharmaceuticals Inc
Name
Telefono
(908) 967-6676
Name
Indirizzo
11 COMMERCE DRIVE, CRANFORD, NJ
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-07
Name
Ultimi documenti SEC
Name
CTXR's Discussions on Twitter

Confronta CTXR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CTXR
Citius Pharmaceuticals Inc
0.68 7.23M 0 -39.14M -28.20M -5.97
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-30 Aggiornamento D. Boral Capital Hold → Buy
2021-11-30 Iniziato Maxim Group Buy

Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie

pulisher
May 29, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World

May 29, 2025
pulisher
May 26, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World

May 26, 2025
pulisher
May 23, 2025

Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN

May 23, 2025
pulisher
May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025
pulisher
May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Maxim Downgrades Citius Oncology to Hold From Buy - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim | CTXR Stock News - GuruFocus

May 23, 2025
pulisher
May 17, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Earns Buy Rating from D. Boral Capital - Defense World

May 17, 2025
pulisher
May 16, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating fr - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments - TipRanks

May 16, 2025
pulisher
May 15, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating from Analyst | CTXR Stock News - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financi - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Laun - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Launch | CTXR Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 14, 2025
pulisher
May 11, 2025

Citius Pharmaceuticals (CTXR) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™ - Barchart.com

May 09, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - The Malaysian Reserve

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | CTXR Stock News - GuruFocus

May 05, 2025
pulisher
May 04, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025
pulisher
Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 By Investing.com - Investing.com Canada

Apr 21, 2025
pulisher
Apr 12, 2025

Citius Pharmaceuticals (CTXR) Price Target Adjusted to $4 Amid S - GuruFocus

Apr 12, 2025
pulisher
Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 - Investing.com Australia

Apr 10, 2025
pulisher
Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025
pulisher
Apr 02, 2025

Citius Pharmaceuticals stock plummets on $2M registered direct offering of common stock - MSN

Apr 02, 2025
pulisher
Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 By Investing.com - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharmaceuticals announces $2M registered direct offering of common stock - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

CTXR’s Stock Woes: Down -87.99% in 6 Months, Down -87.99% in Just 5 Days - investchronicle.com

Mar 31, 2025
pulisher
Mar 28, 2025

IL-2s gain ground as US market heads for $4 billion by 2034 - The Pharma Letter

Mar 28, 2025
pulisher
Mar 28, 2025

Analysts Expect Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) To Breakeven Soon - simplywall.st

Mar 28, 2025
pulisher
Mar 25, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.45 By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.45 - Investing.com India

Mar 25, 2025

Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):